Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation.
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response.
[One case of pediatric multiple sclerosis with convulsions as initial symptoms].
Aminopropyl carbazole analogues as potent enhancers of neurogenesis.
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
Patient-specific early classification of multivariate observations.
Genetic manipulation of microglia during brain development and disease.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
Evaluation of the impact of neutralizing antibodies on IFNβ response.
Correction: Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis.
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility.
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.

Pages